Bone marrow hemodilution assessment in multiple myeloma MRD by next generation flow cytometry - a mini review - Top-Institutions - MDSpire

Bone marrow hemodilution assessment in multiple myeloma MRD by next generation flow cytometry - a mini review

  • By

  • Sorina Nicoleta Badelita

  • Horia Mihail Sandu

  • Daniel Coriu

  • Delia Codruta Popa

  • May 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology

Original Source(s)

Bone marrow hemodilution assessment in multiple myeloma MRD by next generation flow cytometry - a mini review

  • by Sorina Nicoleta Badelita, Horia Mihail Sandu, Daniel Coriu, Delia Codruta Popa

  • May 1, 2026

Related Content

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

High-grade astrocytoma with piloid features: a case report of comprehensive management

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer